The Future of Substance Use Disorder Treatment: A Regulatory Crossroads in 2025
The substance use disorder (SUD) treatment landscape is facing monumental changes in 2025, with several critical regulations poised to reshape the way care is...
The Gold Standard in Opioid Use Disorder Treatment: Addressing Access Challenges and the Growing Concern of Buprenorphine Diversion
Medication-based treatment has long been recognized as the gold standard for treating opioid use disorder (OUD). Medications like buprenorphine are widely regarded for their...
Navigating the Landscape of Substance Use Disorder Treatment in 2024: Challenges, Breakthroughs, and Hope for the Future
The year 2024 in the substance use disorder (SUD) treatment industry has been a dynamic mix of formidable challenges, technological disruptions, and unexpected breakthroughs....
Overdose Deaths Are Twice as High in Medicaid Beneficiaries Compared to All U.S. Residents: An Urgent Public Health Crisis
In a new study published in JAMA, researchers have uncovered a disturbing trend: overdose deaths are nearly twice as high in Medicaid beneficiaries compared...
The Opioid Epidemic: Why the Fight Is Far From Over Despite Declining Overdose Deaths
In recent years, there has been a glimmer of hope in the battle against drug overdose deaths, particularly in parts of the U.S., where...
The Interconnectedness of Operational and Clinical Excellence
Jeff Rosen, who has spent eight years with Sunwave Health, brings a wealth of experience to the conversation. Sunwave Health is a leading behavioral...
